BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353 By: Benzinga via Benzinga October 08, 2015 at 05:59 AM EDT BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that the randomized, placebo-controlled, Phase 1 clinical trial of ... Read More >> Related Stocks: Biocryst Pharma Inc